Relief Therapeutics Holding AG (RLFTF)

[elllk]

Re Pfizer vaccine from NBC news:

In spite of the optimism, the news does not mean a vaccine will be immediately available.

Though there have been no serious safety concerns yet, Pfizer also said, the company added that it would not apply to the U.S. Food and Drug Administration for emergency use authorization until it had two months worth of safety data, which will likely not come until the third week of November.

It is also unclear how long any protection would last, although BioNTech's chief executive, Ugur Sahin, told Reuters, "We should be more optimistic that the immunization effect can last for at least a year." He said it was basing this on earlier findings and research on recovered patients.

Even if approved, rolling out the vaccine worldwide will be an unparalleled logistical challenge. Like many others, this vaccine must be kept at super-cold temperatures, meaning distribution to remote parts of the world will be difficult.